Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies.

Autor: Varian, Frances1,2 (AUTHOR), Dick, Jennifer1 (AUTHOR), Battersby, Christian1 (AUTHOR), Roman, Stefan2 (AUTHOR), Ablott, Jenna2 (AUTHOR), Watson, Lisa2 (AUTHOR), Binmahfooz, Sarah1 (AUTHOR), Zafar, Hamza1,2 (AUTHOR), Colgan, Gerry3 (AUTHOR), Cannon, John4 (AUTHOR), Suntharalingam, Jay5 (AUTHOR), Lordan, Jim6 (AUTHOR), Howard, Luke7 (AUTHOR), McCabe, Colm8 (AUTHOR), Wort, John9 (AUTHOR), Price, Laura9 (AUTHOR), Church, Colin10 (AUTHOR), Hamilton, Neil2 (AUTHOR), Armstrong, Iain2 (AUTHOR), Hameed, Abdul2 (AUTHOR)
Zdroj: Pulmonary Circulation. Jan2024, Vol. 14 Issue 1, p1-13. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje